Screening of SARS-CoV-2 in 299 Hospitalized Children with Hemato-oncological Diseases: A Multicenter Survey in Hubei, China

Abstract

The SARS-CoV-2 infection status of hospitalized children was surveyed in the department of pediatric hematology and oncology in three different hospitals of epidemic areas in Hubei, China. A cross-sectional study was performed to investigate the clinical characteristics, lung CT scan, SARS-CoV-2 nucleic acid test and serum antibodies of hospitalized children with hemato-oncological diseases from January 23 to April 24, 2020. 299 children were enrolled in this study, including 176 males (58.9%) and 123 females (41.1%), aged from 2 months to 16 years. 255 cases (85.3%) received chemotherapy or other immunosuppressive therapies, and there were 44 cases (14.7%) of other benign diseases. Nucleic acid test was performed on 258 children (86.3%) and one case was positive. 163 cases (54.5%) were tested for serum antibodies, and all of them were negative. Lung CT scan was performed on 247 children (82.6%), and 107 of them showed infectious changes. Only one case (0.33%) of COVID-19 was diagnosed in the group. The prevalence rate of COVID-19 in enrolled children with hemato-oncological diseases in Hubei was 0.33%. Immunosuppressed patients are not prone to produce related antibodies. Comprehensive protective measures and ward management can reduce the risk of SARS-CoV-2 infection in the group patients.

Keywords

children / COVID-19 / hemato-oncological diseases / SARS-CoV-2

References

[1] HuangC, WangY, LiX, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223): 497-506

[2] LiangW, GuanW, ChenR, et al.. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol, 2020, 21(3): 335-337

[3] ZhangL, ZhuF, XieL, et al.. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol, 2020, 31(7): 894-901

[4] Epidemiology Working Group for NCIP Epidemic Response. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol (Chinese), 2020, 41(2): 145-151

[5] CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020. NMWR Morb Mortal Wkly Rep, 2020, 69(14): 422-426

[6] Dong Y, Mo X, Hu Y, et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics, 2020. doi: https://doi.org/10.1542/peds.2020-0702

[7] ZhuN, ZhangD, WangW, et al.. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020, 382(8): 727-733

[8] ShenK, YangY. Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue. World J Pediatr, 2020, 16(3): 219-221

[9] OgimiC, EnglundJA, BradfordMC, et al.. Characteristics and outcomes of coronavirus infection in children: the role of viral factors and an immunocompromised state. J Pediatric Infect Dis, Soc, 2019, 8(1): 21-28

[10] ZhaoW, ZhongZ, XieXZ, et al.. Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. AJR Am J Roentgenol, 2020, 214(5): 1072-1077

[11] SueC, KasteDO. Infection Imaging of Children and Adolescents Undergoing Cancer Therapy: A Review of Modalities and an Organ System Approach. Semin Pediatr Infect Dis, 2000, 11(2): 122-141

[12] XuY, LiXF, ZhuB. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat Med, 2020, 26(4): 502-505